Submitted: 06 November 2026 You are already at the latest version PD-1 is an inhibitory receptor on T cells that, when bound by PD-L1 or PD-L2, suppresses anti-tumor immunity. Tumors can exploit this pathway through overexpression of PD-L1, often driven by 9p24.1 chromosomal alterations.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile